Jovanović, M.; Homšek, A.; Marković, S.; Kralj, Đ.; Svorcan, P.; Knežević Ivanovski, T.; Odanović, O.; Vučićević, K.
Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability. Biomedicines 2025, 13, 43.
https://doi.org/10.3390/biomedicines13010043
AMA Style
Jovanović M, Homšek A, Marković S, Kralj Đ, Svorcan P, Knežević Ivanovski T, Odanović O, Vučićević K.
Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability. Biomedicines. 2025; 13(1):43.
https://doi.org/10.3390/biomedicines13010043
Chicago/Turabian Style
Jovanović, Marija, Ana Homšek, Srđan Marković, Đorđe Kralj, Petar Svorcan, Tamara Knežević Ivanovski, Olga Odanović, and Katarina Vučićević.
2025. "Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability" Biomedicines 13, no. 1: 43.
https://doi.org/10.3390/biomedicines13010043
APA Style
Jovanović, M., Homšek, A., Marković, S., Kralj, Đ., Svorcan, P., Knežević Ivanovski, T., Odanović, O., & Vučićević, K.
(2025). Review and External Evaluation of Population Pharmacokinetic Models for Vedolizumab in Patients with Inflammatory Bowel Disease: Assessing Predictive Performance and Clinical Applicability. Biomedicines, 13(1), 43.
https://doi.org/10.3390/biomedicines13010043
